Cambridge, United Kingdom – 27 May 2021 Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, has been featured in the UK’s Digital Health Playbook ‘First 100’. An initiative by the Department of International Trade to highlight the nation’s most innovative and impactful digital health companies  

The First 100 list features UK businesses with a proven track record of benefiting the lives of healthcare professionals and patients across the NHS and private health sector as well as companies whose technology can address the issues facing healthcare systems across the world. Congenica’s inclusion in the list is based on its global track record of solving challenges facing different healthcare systems. The list aims to provide a well-researched credible list for international healthcare organizations and governments to get support for their needs.  

CCS0720890872-005-Digital-Health-Top100-Asset3-Linkedln-1200x627pxl (1)-1

 

The campaign is backed by Healthcare UK, HIMSS, the European Connected Health Alliance (ECHA) Association of British HealthTech Industries (ABHI), Scottish Development International, Innovate UK, and Silver Buck. 

 

David Atkins, CEO of Congenica, said: “It is an honor to be featured in the ‘Future Tech’ category in the First 100 Playbook alongside some of the UK’s most impressive digital health innovators. The inclusion of Congenica is an endorsement of our platform and its utility within the NHS, Genomics England and global healthcare providers. The campaign showcases the strengths of the country’s digital health sector with ground-breaking technologies that can address healthcare challenges globally.” 

 

For more information about Congenica clinical decision support software for rapid and reliable interpretation of complex genomic data, visit www.congenica.com/platform

 

Discover Congenica 

 

Share